SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
S1 Pharmaceuticals, Inc. Announces IND Filing of SIP-104 (Lorexys) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)